AstraZeneca
Catatan dan referensi

1 2 3 4 5  "Preliminary Results 2019" (PDF). AstraZeneca. Diakses tanggal 27 February 2020.
↑  "AstraZeneca". Diakses tanggal 22 October 2020.
↑  "Registered office and corporate headquarters". AstraZeneca. Diakses tanggal 27 February 2020.
↑  "AstraZeneca - About Us". astrazeneca.com.
↑  "AstraZeneca AB".  Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
↑  "Global 500 – Pharmaceuticals". Fortune. 20 July 2009. Diarsipkan dari versi asli tanggal 23 August 2010. Diakses tanggal 19 August 2010.  Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
↑  "Key facts". AstraZeneca. Diarsipkan dari versi asli tanggal 8 September 2010. Diakses tanggal 1 September 2010.  Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
1 2  Carroll, John (18 March 2013). "UPDATED: AstraZeneca to ax 1,600, relocate thousands in global R&D reshuffle". fiercebiotech.com. FierceBiotech.
↑  "Organizational Portraits – AstraZeneca". The Pharmaceutical Century: Ten Decades of Drug Discovery. Washington, D.C.: ACS Publications. 17 November 2000. Diakses tanggal 14 July 2008.
1 2  "Our History - AstraZeneca Careers". AstraZeneca Careers.
↑  "AstraZeneca Selects Wilmington, Del. for New US Headquarters". Diarsipkan dari versi asli tanggal 2018-10-01. Diakses tanggal 2021-02-10.
↑  "AstraZeneca's Iressa FDA committee judgement expected tomorrow". 23 September 2002. Diakses tanggal 7 July 2013.
↑  "ZI is dripping with promise". Diarsipkan dari versi asli tanggal 2014-06-11.  Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
↑  AstraZeneca buys biotech company for £120m The Telegraph, 23 December 2005
↑  AstraZeneca and Astex ally for anticancer agents Business Intelligence, 1 July 2005
↑  "Pennsylvania Bio – Member Listings". Pennsylvania Bio web site. Diarsipkan dari versi asli tanggal 14 December 2005. Diakses tanggal 8 October 2005.
↑  AstraZeneca to buy CAT for £702m BBC News, 15 May 2006
↑  AstraZeneca agrees to buy Arrow Therapeutics for US$150M Marketwatch, 1 February 2007
↑  AstraZeneca seeks a remedy for its patent pain The Telegraph, 21 April 2012
↑  "AstraZeneca to pay $15.2B to purchase rival MedImmune; Deal sees London-based drugmaker take on debt for the first time in order to fill product line". Bloomberg.
↑  AstraZeneca Buys MedImmune for US$ 15.6 Billion The New York Times, 24 April 2007
↑  "AstraZeneca To Acquire Infection Research Company Novexel And Expand Collaboration With Forest Laboratories". 23 December 2009. Diakses tanggal 20 February 2015.
↑  "Novexel to be Acquired by AstraZeneca". Diakses tanggal 20 February 2015.
↑  AstraZeneca to buy Chinese generics firm Healthcare News, 8 December 2011
↑  AstraZeneca and Amgen collaborate on treatments for inflammatory diseases Medcity News, 4 February 2012
↑  AstraZeneca Reaches $1.26 Billion Deal for Ardea Biosciences The New York Times, 23 April 2012
↑  Peacock, Louisa (30 June 2012). "AstraZeneca to pay £2.2bn towards 'joint venture' diabetes deal". The Daily Telegraph. London. Diarsipkan dari versi asli tanggal 2018-10-22. Diakses tanggal 1 July 2012.
1 2  "Bristol-Myers to buy Amylin for about US$5.3 billion". Reuters. 30 June 2012. Diarsipkan dari versi asli tanggal 2012-06-30. Diakses tanggal 1 July 2012.
↑  "AstraZeneca to axe 1,600 jobs in overhaul of drug R&D". Reuters. 18 March 2013. Diarsipkan dari versi asli tanggal 2015-10-19. Diakses tanggal 24 May 2014.
↑  "AstraZeneca cuts UK headcount and moves to Cambridge". Times Higher Education. 19 March 2013. Diakses tanggal 24 May 2014.
↑  "AstraZeneca to cut 2,300 more jobs". USA Today. 21 March 2013. Diakses tanggal 24 May 2014.
↑  "AstraZeneca increase job cuts to 5,050". HR Grapevine. Diakses tanggal 29 October 2014.
↑  AstraZeneca Press Release.  21 March 2013 AstraZeneca outlines strategy to return to growth and achieve scientific leadership
↑  Sandle, Paul (15 October 2013). "AstraZeneca buys oncology-focused Spirogen for up to $440 million". Reuters. Diarsipkan dari versi asli tanggal 2015-10-19. Diakses tanggal 2021-02-10.
↑  "AstraZeneca rejects Pfizer 'final' takeover offer, triggers major drop in shares". London Mercury. Diarsipkan dari versi asli tanggal 20 May 2014. Diakses tanggal 20 May 2014.  Parameter |url-status= yang tidak diketahui akan diabaikan (bantuan)
↑  "AstraZeneca and MTPC come together for research on diabetic nephropathy drugs". Business Sun. 20 August 2014. Diakses tanggal 21 August 2014.
↑  "GEN - News Highlights:Lilly Joins AstraZeneca to Co-Develop BACE Inhibitor for Alzheimer's". GEN.
↑  "GEN - News Highlights:AstraZeneca Bolsters Oncology Focus with Definiens Purchase, Trial Collaboration". GEN.
↑  "GEN - News Highlights:Aegerion Snaps Up Rare Disease Drug from AstraZeneca for US$325M+". GEN.
↑  Planasari, Sita (2024-05-01). "Untuk Pertama Kali, AstraZeneca Akui Vaksin Covidnya Punya Efek Samping Langka". Tempo (dalam bahasa Inggris). Diakses tanggal 2024-05-02.
↑  Indonesia, C. N. N. "Vaksin Covid-19 AstraZeneca Disebut Picu Efek Samping TTS, Apa Itu?". gaya hidup. Diakses tanggal 2024-05-02.
↑  Planasari, Sita (2024-05-01). "Untuk Pertama Kali, AstraZeneca Akui Vaksin Covidnya Punya Efek Samping Langka". Tempo (dalam bahasa Inggris). Diakses tanggal 2024-05-02.
↑  "AstraZeneca Akhirnya Akui Vaksin Covid-19 Produksinya Punya Efek Samping, Bisa Sebabkan Kematian". SINDOnews Lifestyle. Diakses tanggal 2024-05-02.
↑  Planasari, Sita (2024-05-01). "Untuk Pertama Kali, AstraZeneca Akui Vaksin Covidnya Punya Efek Samping Langka". Tempo (dalam bahasa Inggris). Diakses tanggal 2024-05-02.